United Therapeutics earnings were $1.2B for the trailing 12 months ending Mar 31, 2025, with 21.1% growth year over year. The latest UTHR earnings report on Mar 31, 2025 announced Q1 2025 earnings of $322.2M, up 6.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UTHR reported annual earnings of $1.2B, with 21.4% growth.
UTHR past earnings growth
How has UTHR's earnings growth performed historically?
United Therapeutics Earnings Reports & History FAQ
What were United Therapeutics's earnings last quarter?
On UTHR's earnings call on Invalid Date, United Therapeutics (NASDAQ: UTHR) reported Q1 2025 earnings per share (EPS) of $7.18, up 10.12% year over year. Total UTHR earnings for the quarter were $322.20 million. In the same quarter last year, United Therapeutics's earnings per share (EPS) was $6.52.
Is United Therapeutics profitable or losing money?
As of the last United Therapeutics earnings report, United Therapeutics is currently profitable. United Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $1.21 billion, a 15.25% increase year over year.
What was UTHR's earnings growth in the past year?
As of United Therapeutics's earnings date in Invalid Date, United Therapeutics's earnings has grown 21.11% year over year. This is 9.11 percentage points higher than the US Biotechnology industry earnings growth rate of 12%. UTHR earnings in the past year totalled $1.21 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.